184 related articles for article (PubMed ID: 709913)
1. Inhibition of lymphocyte cytotoxicity in chronic active hepatitis.
Kakumu S; Hara T; Gohji H; Sakamoto N
Clin Exp Immunol; 1978 Jul; 33(1):71-8. PubMed ID: 709913
[TBL] [Abstract][Full Text] [Related]
2. IgG.antibody-dependent cell-mediated cytotoxicity against cultured liver cells in patients with chronic active hepatitis.
Nonomura A; Shintani T; Ohta G
Jpn J Exp Med; 1978 Oct; 48(5):381-92. PubMed ID: 748618
[TBL] [Abstract][Full Text] [Related]
3. In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.
Vierling JM; Nelson DL; Strober W; Bundy DM; Jones EA
J Clin Invest; 1977 Nov; 60(5):1116-28. PubMed ID: 332716
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immunity in acute and chronic hepatitis.
Wands JR; Perrotto JL; Alpert E; Isselbacher KJ
J Clin Invest; 1975 May; 55(5):921-9. PubMed ID: 1079030
[TBL] [Abstract][Full Text] [Related]
5. LM-Ag and LSP--two different target antigens involved in the immunopathogenesis of chronic active hepatitis?
Meyer zum Büschenfelde KH; Manns M; Hütteroth TH; Hopf U; Arnold W
Clin Exp Immunol; 1979 Aug; 37(2):205-12. PubMed ID: 498582
[TBL] [Abstract][Full Text] [Related]
6. Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B.
Meliconi R; Baraldini M; Stefanini GF; Facchini A; Miglio F; Bortolotti F; Alberti A; Realdi G; Amoroso P
Clin Exp Immunol; 1981 Nov; 46(2):382-90. PubMed ID: 6802539
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte transformation test with rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
Ortona L; Laghi V; Cauda R; Nervo P
Clin Exp Immunol; 1979 Nov; 38(2):231-4. PubMed ID: 527260
[TBL] [Abstract][Full Text] [Related]
8. Direct and serum-induced lymphocytotoxicity against rabbit hepatocytes in chronic active hepatitis.
Ortona L; Laghi V; Cauda R; Nervo P
Boll Ist Sieroter Milan; 1981; 60(1):46-51. PubMed ID: 7272012
[TBL] [Abstract][Full Text] [Related]
9. Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).
Warnatz H; Rösch W; Gerlich W; Gutmann W
Clin Exp Immunol; 1979 Jan; 35(1):133-40. PubMed ID: 371882
[TBL] [Abstract][Full Text] [Related]
10. Incidence of antibodies against rabbit liver specific lipoprotein (RLSP) in chronic active hepatitis.
Ortona L; Laghi V; Tamburrini E; Troncone L; Bonifazi N; Nervo P; Cauda R
Clin Exp Immunol; 1983 May; 52(2):437-40. PubMed ID: 6861379
[TBL] [Abstract][Full Text] [Related]
11. In-vitro cell-mediated cytotoxicity for autologous liver cells in chronic non-A, non-B hepatitis.
Mondelli M; Alberti A; Tremolada F; Williams R; Eddleston AL; Realdi G
Clin Exp Immunol; 1986 Jan; 63(1):147-55. PubMed ID: 3082546
[TBL] [Abstract][Full Text] [Related]
12. [Direct and induced lymphocytotoxicity to rabbit hepatocytes in chronic active hepatitis].
Laghi V; Cauda R; Nervo P
Arch Sci Med (Torino); 1980; 137(4):575-7. PubMed ID: 7247672
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis.
Vergani GM; Vergani D; Jenkins PJ; Portmann B; Mowat AP; Eddleston AL; Williams R
Clin Exp Immunol; 1979 Oct; 38(1):16-21. PubMed ID: 393438
[TBL] [Abstract][Full Text] [Related]
14. The IgG antibody reactivity of sera from patients with active chronic hepatitis to a crude liver antigen and liver specific protein (LSP): analysis by ELISA and immunoblotting.
Sundin U; Heigl Z; Sundqvist KG
Clin Exp Immunol; 1988 Nov; 74(2):276-82. PubMed ID: 3265656
[TBL] [Abstract][Full Text] [Related]
15. Antibody dependent cellular cytotoxicity (ADCC) in acute hepatitis B and in chronic active hepatitis.
Bortolotti F; Realdi G; Diodati G; Fattovich G
Clin Exp Immunol; 1978 Aug; 33(2):211-6. PubMed ID: 719950
[TBL] [Abstract][Full Text] [Related]
16. "Anti-Ia reactivity in sera from patients with chronic active hepatitis (CAH)".
Levrero M; Barnaba V; Paroli M; Valesini G; Franco A; Laghi V; Cauda R; Balsano F
J Clin Lab Immunol; 1987 Oct; 24(2):63-8. PubMed ID: 2963916
[TBL] [Abstract][Full Text] [Related]
17. In vitro studies on IgG-mediated lymphocyte cytotoxicity in chronic active liver disease.
Kawanishi H
Gastroenterology; 1977 Sep; 73(3):549-55. PubMed ID: 892355
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte cytotoxicity in alcoholic hepatitis.
Kakumu S; Leevy CM
Gastroenterology; 1977 Apr; 72(4 Pt 1):594-7. PubMed ID: 65306
[TBL] [Abstract][Full Text] [Related]
19. Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen.
Sagnelli E; Felaco FM; Triolo G; Vernace SJ; Filippini P; Piccinino F; Behrens U; Paronetto F
J Clin Lab Immunol; 1983 Sep; 12(1):11-5. PubMed ID: 6195340
[TBL] [Abstract][Full Text] [Related]
20. Antibodies to ribosomes in chronic active hepatitis.
Gerber MA; Shapiro JM; Smith H; Lebwohl O; Schaffner F
Gastroenterology; 1979 Jan; 76(1):139-43. PubMed ID: 758135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
